An illustrative case drawn from the pattern of veteran patients the Valor team sees: a Marine veteran with 14 years of service-connected low back pain, facing a two-level lumbar fusion recommendation, followed a structured escalation of conservative care and biologic disc repair — and at 18 months, his VAS pain score had dropped from 7/10 to 2/10, he was opioid-free, and surgery was off the table.

Note: The following is a composite illustrative scenario reflecting patterns commonly seen in veterans with disc-related back pain. It does not represent a specific individual. All details are generalized to protect patient privacy.

What Does a Typical Veteran Disc Pain Journey Look Like Before Reaching This Point?

The pattern in this illustrative case is one the Valor team encounters consistently: a veteran whose chronic low back pain originated during active service, persisted through separation, and escalated through a VA care cycle that offered escalating medications and an eventual surgical recommendation — but no intermediate option that addressed the disc tears themselves.

In this scenario, the veteran is a Marine Corps veteran who served two combat deployments before separating in his late 30s. His chronic low back pain originated during a fast-rope insertion training cycle and was compounded by years of carrying combat loads. By the time he arrived at Valor, he was 14 years into a pattern that is common for this population. According to VA and VHA epidemiological data, 65.6% of veterans report pain in the past three months. This illustrative patient was not an outlier — which is exactly why the case is instructive.

VA Care History Before Evaluation

The prior treatment history in this scenario included:

• Multiple courses of physical therapy across three different VA facilities — each course 6 to 12 visits, with no continuity of provider
• Three lumbar epidural steroid injections over four years, each with diminishing returns
• A short-term opioid prescription that became long-term
• An MRI showing two-level disc degeneration with annular tears at L4-L5 and L5-S1
• A surgical consultation recommending two-level lumbar fusion

The epidural steroid injections reflect a pattern documented in the literature: an AAFP systematic review found ESIs “not effective” for chronic low back pain as a standalone treatment. This patient arrived looking for an off-ramp from the surgical track — and a clinical evaluation confirmed he was a reasonable candidate for a different path.

How Was the Non-Surgical Treatment Plan Structured?

The clinical reasoning followed a deliberate stepladder. Before any procedural intervention was considered, the goal was to optimize the patient’s loading capacity, movement quality, and pain modulation through structured conservative care. Patients considering alternatives to spinal fusion should expect this same logic: fusion is not the first option after conservative care stalls — it is a last resort after every reasonable intermediate step has been exhausted.

Phase 1 Goals (Months 0–3)

• Re-establish a consistent movement program with a single provider
• Wean off opioids using a non-opioid pain management plan
• Determine whether the annular tears were the primary pain generators or incidental imaging findings
• Build the strength base needed to support any future biologic procedure

Phase 2 Goals (Months 3–9)

• Trial intra-annular fibrin injection if pain remained activity-limiting
• Resume veteran-relevant functional tasks: ruck walks, lifting, ladder work
• Reduce reliance on as-needed analgesics

Phase 3 Goals (Months 9–18)

• Demonstrate durable function at 12 and 18 months
• Confirm surgical candidacy was no longer clinically indicated
• Transition to a maintenance program

What Did the 18-Month Timeline Actually Look Like?

Months 0–3: Conservative Foundation

The patient began a twice-weekly directed exercise program focused on hip mobility, posterior chain strength, and graded lumbar loading. A single provider managed the entire phase — a structural improvement over the fragmented VA experience. A dry-needling protocol addressed persistent paraspinal trigger points. Opioid taper began in week three, supported by topical agents and a structured sleep protocol.

By the end of month three, VAS pain had moved from 7/10 to 5/10. The patient was opioid-free. Functionally, however, he was not restored — pain remained activity-limiting with loaded carries and prolonged standing.

Months 3–6: Diagnostic Confirmation and Procedural Planning

Updated MRI confirmed the original two-level disc pathology with annular tears unchanged. Given his imaging findings, his demonstrated adherence to the conservative program, and his clear preference to avoid fusion, the patient was evaluated as a reasonable candidate for biologic disc repair. He was counseled on realistic expectations for intra-annular fibrin injection — including that population-level outcome data shows an 83% success rate across more than 7,000 procedures with long-term follow-up, and that individual outcomes vary. A clinical evaluation, not a general statistic, is the basis for any treatment decision.

An annulogram — an imaging-guided diagnostic step that identifies every tear and leak in the discs before treatment — confirmed L4-L5 and L5-S1 as the primary pain generators. This diagnostic step is what separates a targeted biologic approach from a general injection: the clinician knows exactly which discs to treat before the therapeutic procedure begins.

Month 6: Intra-Annular Fibrin Injection

The fibrin procedure was performed under imaging guidance. The FDA-approved fibrin sealant was delivered through a thin catheter to both affected disc levels. The procedure required less than one hour, used light sedation, and required no incisions. The patient was discharged the same day and returned to modified activity within 72 hours.

Months 6–12: Structured Recovery and Functional Rebuild

Post-procedure rehabilitation followed a progressive protocol: walking in weeks one through four, then resistance training at month two, then loaded carries reintroduced at month four. VAS pain at the three-month post-procedure mark was 3/10. At month six post-procedure, the patient completed his first weighted ruck walk — 3 miles at 30 pounds — without a pain flare. VAS at that point: 2/10.

Month 18: Outcomes Assessment

At 18 months from the start of the program — 12 months from the fibrin procedure — the clinical picture was:

• VAS pain score: 2/10 (baseline: 7/10)
• Opioid use: none
• Functional status: ruck walks, light strength training, full activities of daily living
• Surgical status: two-level lumbar fusion no longer clinically indicated

How Does the Mission Act Apply to Cases Like This?

Veterans whose VA facility cannot provide timely or appropriate care for their condition may be eligible to receive care at a non-VA provider under the Mission Act — and the procedure may be a covered VA benefit under those criteria. VA coverage is determined case-by-case by the VA, not by Valor Spine. Valor coordinates the referral process directly with VA referral coordinators so the veteran does not have to navigate the system alone.

In this illustrative scenario, the patient’s access to non-VA spine care was facilitated through the Mission Act referral pathway. Veterans in similar situations — chronic disc-related pain, failed VA conservative care, surgical recommendation they want to avoid — should ask their VA primary care provider about a Mission Act referral or contact Valor directly to discuss what the process looks like.

For more detail on how the referral process works, see Veterans: Regenerative Spine Care & Insurance FAQ.

What Makes This Case Applicable to Other Veterans?

The Valor team does not present this scenario as a guarantee of what any individual patient will experience. What makes it instructive is its representativeness: the presenting pattern — combat-load injury, fragmented VA care, ESI failure, opioid escalation, surgical recommendation — reflects what the data shows for this population. For veterans in that pattern, biologic disc repair as an intermediate step between failed conservative care and fusion is a clinically documented option worth evaluating. See also: Avoiding Lumbar Fusion with Intra-Annular Fibrin Injection: How an Army Infantry Veteran Achieved 24-Month Pain Relief and Veteran’s Sciatica: From Fusion Fear to Lasting Relief.

A clinical evaluation is the only way to know for certain whether the fibrin procedure is appropriate for any specific patient’s anatomy, history, and goals.

Frequently Asked Questions

Is this case study about a real patient?

No. This is a composite illustrative scenario drawn from patterns the Valor team sees in veteran patients with disc-related back pain. No real patient is identified. All details are generalized. Individual outcomes vary.

What is intra-annular fibrin injection and how does it differ from an epidural steroid injection?

An epidural steroid injection delivers anti-inflammatory medication into the space around the spinal cord — it does not address the disc tear itself. Intra-annular fibrin injection delivers an FDA-approved fibrin sealant directly into the disc through the annular tear, with the goal of sealing the tear and allowing the disc to heal from within. The two procedures target different structures and serve different clinical purposes.

How long does the fibrin procedure take and what is recovery like?

The procedure is typically completed in under one hour, uses local anesthesia or light sedation, and requires no incisions. Most patients are discharged the same day. A structured rehabilitation protocol follows, with progressive return to activity over several months. Individual recovery timelines vary based on clinical presentation and the number of disc levels treated.

Can veterans access this procedure through the VA?

The procedure may be a covered VA benefit under the Mission Act when the VA cannot provide timely or appropriate care. VA coverage is determined case-by-case by the VA. Valor Spine works directly with VA referral coordinators to manage the paperwork — veterans do not have to navigate the process alone. A consultation is the first step to understanding whether a Mission Act referral applies to a specific situation.

What are the outcome data for this type of procedure?

Among the most-tracked outcomes — over 7,000 procedures with long-term follow-up — the success rate is 83%. In published fibrin studies, VAS pain scores moved from a baseline of 72.4mm to 33.0mm at 104 weeks. These are population-level statistics; individual outcomes vary, and a clinical evaluation is the basis for any treatment decision.

What if a veteran has already had back surgery that did not work?

Outcome registry data shows that 80% of patients who had prior spine surgery and then received fibrin disc treatment reported positive outcomes — though individual outcomes vary and prior surgical history affects candidacy. For patients dealing with failed prior surgery, see From Failed Surgery to Freedom: Non-Surgical Spine Recovery. A clinical evaluation determines whether biologic disc repair is appropriate given a specific surgical history.

How do I find out if I am a candidate?

A clinical evaluation — including review of existing MRI and a consultation with the Valor clinical team — is the only way to know for certain. Valor offers a no-cost MRI review as a starting point. Schedule a consultation to discuss your history and whether the fibrin procedure is a reasonable next step for your situation.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.

The fibrin sealant used in the procedure is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient.

VA coverage is determined case-by-case under Mission Act criteria by the VA, not by Valor Spine. Valor coordinates the referral process; the VA makes coverage decisions.